Home » Topics » Regulatory » Patents

Patents
RSS

Daiichi Sankyo and collaborator patent TNSALP inhibitors

July 19, 2018

Merck & Co. divulges FFA1 receptor agonists

July 18, 2018

Oligomerix presents tau aggregation inhibitors

July 18, 2018

Italian researchers identify compounds for kinetoplastid infections

July 18, 2018

Ono Pharmaceutical synthesizes PTK6 inhibitors

July 18, 2018

Roche and C4 Therapeutics patent EGFR mutant inhibitors

July 18, 2018

Lundbeck discloses PDE1 inhibitors

July 17, 2018

Orion presents CYP11A1 inhibitors

July 17, 2018

Bayer divulges new B1 receptor antagonists

July 17, 2018

Nanjing Carephar Shenghui Pharmaceutical Co. divulges RORgammaT antagonists

July 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...